Stride, Inc. (LRN) shares fell 12.38 percent to $138.75 on Monday, sliding $18.53, after Conceivable Life Sciences announced a $50 million Series A financing round to advance development of the world's first AI-powered automated IVF laboratory. The investment aims to scale and commercialize IVF technology for improved pregnancy outcomes. The stock opened at $158.00 and traded between $136.25 and $158.40, compared with a prior close of $158.36 on the New York Stock Exchange. Trading volume reached 1.3 million shares, well above the average of 637,459. Stride now trades within a 52-week range of $63.25 to $171.17.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.